YouTube Deep SummaryYouTube Deep Summary

Star Extract content that makes a tangible impact on your life

Video thumbnail

Trade Tracker: Josh Brown Sells Pfizer

CNBC Television • 1:26 minutes • Published 2025-07-17 • YouTube

📝 Transcript (50 entries):

We're just bringing it back to weight as a as a sector within our portfolio. >> All right Josh let me get to one of your moves as well. This one in the pharma space. It's Pfizer. You've been a long time holder of Pfizer. You decided to change your position there. What's the motivation? >> Do you know how hard it. >> Is to find a stock as bad as Pfizer? Like in the last couple of years, I managed the impossible. I haven't really lost a lot of money here. I think my initial purchase was like 28, but it's a it's a loss nonetheless. But the way I think about these types of things, it's a loss relative to the overall market having gone up so much, which makes it even worse. And I stuck to my guns on this for no reason. I'm not really a value investor, but I just felt the stock was so hated and down so much that it was a relatively low risk entry, and at some point they'd find a way to turn it around. I was right about the lowest entry part, but I was dead wrong. There is no turnaround. Maybe it will happen starting today. Now that I'm no longer in the stock. I've seen that before too. But look, the problem here is opportunity cost. I'm only going to have so many holdings. I'm only going to have so much capital for equities, individual stocks. And this just does not fit with my strategy. So as much as I would have loved to have come on the show and said, remember I told you Pfizer 28. Look, I was right. The company's turning it around. The stock is 40. I don't get to do that. I was dea